RCM Technologies (RCMT) Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for RCM Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RCMT shares.
View RCMT analyst ratings or view top-rated stocks.

1 brokers have issued 1 year price targets for RCM Technologies' shares. Their RCMT share price forecasts range from $22.00 to $22.00. On average, they anticipate the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 9.1% from the stock's current price.
View analysts price targets for RCMT or view top-rated stocks among Wall Street analysts.

RCM Technologies' stock was trading at $12.34 at the beginning of the year. Since then, RCMT stock has increased by 63.5% and is now trading at $20.17.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our RCMT earnings forecast.

RCM Technologies, Inc. (NASDAQ:RCMT) released its quarterly earnings data on Wednesday, August, 9th. The business services provider reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by $0.01. The business services provider earned $67.04 million during the quarter, compared to analyst estimates of $66.37 million. RCM Technologies had a net margin of 6.16% and a trailing twelve-month return on equity of 53.97%.

Ballast Small/Mid Cap ETF holds 40,937 shares of RCMT stock, representing 0.89% of its portfolio.

39 employees have rated RCM Technologies Chief Executive Officer Rocco Campanelli on Glassdoor.com. Rocco Campanelli has an approval rating of 65% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other RCM Technologies investors own include Tilly's (TLYS), ADMA Biologics (ADMA), Zosano Pharma (ZSAN), DHT (DHT), Enerplus (ERF), Gran Tierra Energy (GTE), Hallador Energy (HNRG), Matinas BioPharma (MTNB), Novan (NOVN) and Organigram (OGI).

RCM Technologies trades on the NASDAQ under the ticker symbol "RCMT."

RCM Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (7.23%), Dimensional Fund Advisors LP (3.84%), Kent Lake Capital LLC (1.28%), Kerrisdale Advisers LLC (1.28%), Geode Capital Management LLC (0.82%) and O Shaughnessy Asset Management LLC (0.65%). Insiders that own company stock include Bradley Vizi, Kevin D Miller, Michael Saks, Richard A Genovese and Roger H Ballou.
View institutional ownership trends.

Shares of RCMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RCMT stock can currently be purchased for approximately $20.17.

RCM Technologies (NASDAQ:RCMT) has a market capitalization of $160.96 million and generates $284.68 million in revenue each year. The business services provider earns $20.89 million in net income (profit) each year or $1.69 on an earnings per share basis.

The company employs 3,260 workers across the globe.

RCM Technologies' mailing address is 2500 MCCLELLAN AVENUE SUITE 350, PENNSAUKEN NJ, 08109. The official website for the company is www.rcmt.com. The business services provider can be reached via phone at (856) 356-4500, via email at info@rcmt.com, or via fax at 856-356-4600.